{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:35:25Z","timestamp":1770748525506,"version":"3.50.0"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Stem cells are capable of self-renewal, differentiation, and the promotion of the release of chemokines and progenitor cells essential for tissue regeneration. Stem cells have the potential to develop into specialized cells if given the right conditions, to self-renew and maintain themselves, to generate a large number of new differentiated cells if injured, and to either generate new tissues or repair existing ones. In the last decade, it has become clear that treating lower urinary tract dysfunction with the patient's own adult stem cells is an effective, root-cause method. Regenerative medicine is predicated on the idea that a damaged rhabdosphincter can be repaired, leading to enhanced blood flow and improved function of the sphincter's exterior (striated) and internal (smooth) muscles. Stem cell therapy has the potential to cure stress urinary incontinence according to preclinical models. In contrast, stem cell treatment has not been licensed for routine clinical usage. This article reviews the current state of stem cell for stres urinary incontinence research and recommends future avenues to facilitate practical uses of this potential therapy modality.<\/jats:p>","DOI":"10.3389\/fmed.2022.1073758","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T08:49:45Z","timestamp":1669970985000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Current status of stem cell treatments and innovative approaches for stress urinary incontinence"],"prefix":"10.3389","volume":"9","author":[{"given":"Mehmet Murat","family":"Seval","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazibe","family":"Koyuncu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/01.AOG.0000267220.48987.17","article-title":"Urinary incontinence in women: variation in prevalence estimates and risk factors","volume":"111","author":"Minassian","year":"2008","journal-title":"Obstet Gynecol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/aje\/kwm356","article-title":"Prevalence of and risk factors for urine leakage in a racially and ethnically diverse population of adults: the Boston Area Community Health (BACH) Survey","volume":"167","author":"Tennstedt","year":"2008","journal-title":"Am J Epidemiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/AOG.0b013e3181660c1b","article-title":"Prevalence and co-occurrence of pelvic floor disorders in community-dwelling women","volume":"111","author":"Lawrence","year":"2008","journal-title":"Obstet Gynecol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1001\/jama.300.11.1311","article-title":"Prevalence of symptomatic pelvic floor disorders in US women","volume":"300","author":"Nygaard","year":"2008","journal-title":"JAMA."},{"key":"B5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/AOG.0000000000000057","article-title":"Prevalence and trends of symptomatic pelvic floor disorders in US women","volume":"123","author":"Wu","year":"2014","journal-title":"Obstet Gynecol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/nau.20668","article-title":"Prevalence of urinary incontinence and associated risk factors in nursing home residents: a systematic review","volume":"28","author":"Offermans","year":"2009","journal-title":"Neurourol Urodyn."},{"key":"B7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S0022-5347(05)00242-9","article-title":"The prevalence of urinary incontinence among community dwelling adult women: results from the National Health and Nutrition Examination Survey","volume":"175","author":"Anger","year":"2006","journal-title":"J Urol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1532-5415.1998.tb02469.x","article-title":"Variation in estimates of urinary incontinence prevalence in the community: effects of differences in definition, population characteristics, and study type","volume":"46","author":"Thom","year":"1998","journal-title":"J Am Geriatr Soc."},{"key":"B9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1089\/jwh.2013.4382","article-title":"Stress urinary incontinence in younger women in primary care: prevalence and opportunistic intervention","volume":"23","author":"Ng","year":"2014","journal-title":"J Womens Health."},{"key":"B10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/SPV.0000000000000365","article-title":"Trends in ambulatory management of urinary incontinence in women in the United States","volume":"23","author":"Forde","year":"2017","journal-title":"Female Pelvic Med Reconstr Surg."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00192-012-1743-x","article-title":"The iceberg of health care utilization in women with urinary incontinence","volume":"23","author":"Minassian","year":"2012","journal-title":"Int Urogynecol J."},{"key":"B12","first-page":"S574","article-title":"Comorbidities associated with overactive bladder","volume":"6","author":"Brown","year":"2000","journal-title":"Am J Manag Care"},{"key":"B13","first-page":"S598","article-title":"Health-related consequences of overactive bladder","volume":"8","author":"Wagner","year":"2002","journal-title":"Am J Manag Care"},{"key":"B14","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.stemcr.2017.12.007","article-title":"Real-Time Monitoring of Glutathione in Living Cells Reveals that High Glutathione Levels Are Required to Maintain Stem Cell Function","volume":"10","author":"Jeong","year":"2018","journal-title":"Stem Cell Reports"},{"key":"B15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s11934-013-0358-1","article-title":"Update on behavioral and physical therapies for incontinence and overactive bladder: the role of pelvic floor muscle training","volume":"14","author":"Burgio","year":"2013","journal-title":"Curr Urol Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1161\/CIRCRESAHA.116.309362","article-title":"novel view of the adult stem cell compartment from the perspective of a quiescent population of very small embryonic-like stem cells","volume":"120","author":"Ratajczak","year":"2017","journal-title":"Circ Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1016\/j.celrep.2017.01.074","article-title":"Sirt1 regulates DNA methylation and differentiation potential of embryonic stem cells by antagonizing Dnmt3l","volume":"18","author":"Heo","year":"2017","journal-title":"Cell Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15283\/ijsc17061","article-title":"Mesenchymal stem cell therapy for ischemic heart disease: systematic review and meta-analysis","volume":"11","author":"Jeong","year":"2018","journal-title":"Int J Stem Cells."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1038\/s41375-018-0151-8","article-title":"Small hypoxia-primed mesenchymal stem cells attenuate graft-versus-host disease","volume":"32","author":"Kim","year":"2018","journal-title":"Leukemia."},{"key":"B20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.stemcr.2017.12.007","article-title":"Real-time monitoring of glutathione in living cells reveals that high glutathione levels are required to maintain stem cell function","volume":"10","author":"Jeong","year":"2018","journal-title":"Stem Cell Reports."},{"key":"B21","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/S0140-6736(99)02588-X","article-title":"Urinary incontinence in the elderly and age-dependent apoptosis of rhabdosphincter cells","volume":"354","author":"Strasser","year":"1999","journal-title":"Lancet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1447-0756.2010.01232.x","article-title":"Recurrent urinary stress incontinence: an overview","volume":"36","author":"Ashok","year":"2010","journal-title":"J Obstet Gynaecol Res."},{"key":"B23","year":"2008","journal-title":"FDA Public Health Notification: Serious Complications Associated With Transvaginal Placement of Surgical Mesh in Repair of Pelvic Organ Prolapse and Stress Urinary Incontinence"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1126\/science.287.5457.1442","article-title":"Translating stem and progenitor cell biology to the clinic: barriers and opportunities","volume":"287","author":"Weissman","year":"2000","journal-title":"Science."},{"key":"B25","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1098\/rstb.1998.0247","article-title":"Epidermal stem cells: markers, patterning and the control of stem cell fate","volume":"353","author":"Watt","year":"1998","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1126\/science.287.5457.1433","article-title":"Mammalian neural stem cells","volume":"287","author":"Gage","year":"2000","journal-title":"Science."},{"key":"B27","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0094-1298(20)31020-8","article-title":"The mesengenic process","volume":"21","author":"Caplan","year":"1994","journal-title":"Clin Plast Surg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S8756-3282(99)00084-8","article-title":"Interconversion potential of cloned human marrow adipocytes in vitro","volume":"24","author":"Park","year":"1999","journal-title":"Bone."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/nature04697","article-title":"Pluripotency of spermatogonial stem cells from adult mouse testis","volume":"440","author":"Guan","year":"2006","journal-title":"Nature."},{"key":"B30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00192-010-1255-5","article-title":"Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study","volume":"22","author":"Sebe","year":"2011","journal-title":"Int Urogynecol J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ijgo.2011.11.029","article-title":"Intrasphincteric autologous myoblast injections with electrical stimulation for stress urinary incontinence","volume":"117","author":"Blaganje","year":"2012","journal-title":"Int J Gynaecol Obstetr."},{"key":"B32","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00192-007-0553-z","article-title":"1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence","volume":"19","author":"Carr","year":"2008","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct."},{"key":"B33","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.juro.2012.09.028","article-title":"Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study","volume":"189","author":"Carr","year":"2013","journal-title":"J Urol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/iju.13886","article-title":"Treatment of male stress urinary incontinence using autologous adipose-derived regenerative cells: Long-term efficacy and safety","volume":"26","author":"Gotoh","year":"2019","journal-title":"Int J Urol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.juro.2014.02.047","article-title":"Autologous muscle derived cells for treatment of stress urinary incontinence in women","volume":"192","author":"Peters","year":"2014","journal-title":"J Urol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/nau.22404","article-title":"Autologous muscle-derived cells for the treatment of female stress urinary incontinence: a 2- year follow-up of a polish investigation","volume":"33","author":"Stangel-Wojcikiewicz","year":"2014","journal-title":"Neurourol Urodyn."},{"key":"B37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.17772\/gp\/61330","article-title":"Quality of life assessment in female patients 2 and 4 years after muscle-derived cell transplants for stress urinary incontinence treatment","volume":"87","author":"Stangel-Wojcikiewicz","year":"2016","journal-title":"Ginekol Pol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/nau.23068","article-title":"A novel cell therapy for stress urinary incontinence, midterm out come","volume":"36","author":"Keshvari Shirvan","year":"2017","journal-title":"Neurourol Urodyn."},{"key":"B39","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/nau.22301","article-title":"novel cell therapy for stress urinary incontinence, short-term outcome","volume":"32","author":"Shirvan","year":"2013","journal-title":"Neurourol Urodyn."},{"key":"B40","doi-asserted-by":"publisher","first-page":"936","DOI":"10.5966\/sctm.2013-0197","article-title":"Autologous adipose stem cells in treatment of female stress urinary incontinence: results of a pilot study","volume":"3","author":"Kuismanen","year":"2014","journal-title":"Stem Cells Transl Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.juro.2007.08.154","article-title":"Myoblast and fibroblast therapy for post-prostatectomy urinary incontinence: 1-year followup of 63 patients","volume":"179","author":"Mitterberger","year":"2008","journal-title":"J Urol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"898535","DOI":"10.1100\/2012\/898535","article-title":"Muscle-derived cells for treatment of iatrogenic sphincter damage and urinary incontinence in men","volume":"2012","author":"Gerullis","year":"2012","journal-title":"Sci World J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1442-2042.2012.02999.x","article-title":"Periurethral injection of autologous adipose-derived regenerative cells for the treatment of male stress urinary incontinence: Report of three initial cases","volume":"19","author":"Yamamoto","year":"2012","journal-title":"Int J Urol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.3349\/ymj.2016.57.5.1152","article-title":"Adipose-derived regenerative cell injection therapy for postprostatectomy incontinence: a phase I clinical study","volume":"57","author":"Choi","year":"2016","journal-title":"Yonsei Med J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.7150\/ijms.22130","article-title":"Cell therapy clinical trials for stress urinary incontinence: current status and perspectives","volume":"15","author":"Aragon","year":"2018","journal-title":"Int J Med Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3727\/096368914X681937","article-title":"Human infrapatellar fat pad-derived stromal cells have more potent differentiation capacity than other mesenchymal cells and can be enhanced by hyaluronan","volume":"24","author":"Ding","year":"2015","journal-title":"Cell Transplant."},{"key":"B47","first-page":"368","article-title":"Concomitant transurethral and transvaginal-periurethral injection of autologous adipose derived stem cells for treatment of female stress urinary incontinence: a phase one clinical trial","volume":"55","author":"Arjmand","year":"2017","journal-title":"Acta Med Iran."},{"key":"B48","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/2090598X.2020.1750864","article-title":"Stem cell applications in regenerative medicine for stress urinary incontinence: a review of effectiveness based on clinical trials","volume":"18","author":"Barakat","year":"2020","journal-title":"Arab J Urol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.1016\/j.biomaterials.2007.09.008","article-title":"Muscle-derived stem cells for tissue engineering and regenerative therapy","volume":"28","author":"Usas","year":"2007","journal-title":"Biomaterials."},{"key":"B50","doi-asserted-by":"publisher","first-page":"7060975","DOI":"10.1155\/2016\/7060975","article-title":"Stem cell therapy for treatment of stress urinary incontinence: the current status and challenges","volume":"2016","author":"Zhou","year":"2016","journal-title":"Stem Cells Int."},{"key":"B51","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/iju.13097","article-title":"Effect of autologous muscle-derived cells in the treatment of urinary incontinence in female patients with intrinsic sphincter deficiency and epispadias: a prospective study","volume":"23","author":"Sharifiaghdas","year":"2016","journal-title":"Int J Urol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1007\/s11255-018-2005-8","article-title":"A double-blind, randomized, placebo-controlled clinical trial evaluating the safety and efficacy of autologous muscle derived cells in female subjects with stress urinary incontinence","volume":"50","author":"Jankowski","year":"2018","journal-title":"Int Urol Nephrol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ijgo.13853","article-title":"The effect of skeletal muscle-derived cells implantation on stress urinary incontinence and functional urethral properties in female patients","volume":"157","author":"Blaganje","year":"2022","journal-title":"Int J Gynaecol Obstet."},{"key":"B54","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3727\/096368915X686841","article-title":"Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy","volume":"24","author":"Ding","year":"2015","journal-title":"Cell Transplant."},{"key":"B55","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3346\/jkms.2010.25.6.813","article-title":"Human cord blood stem cell therapy for treatment of stress urinary incontinence","volume":"25","author":"Lee","year":"2010","journal-title":"J Korean Med Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/scrt458","article-title":"Urine-derived stem cells for potential use in bladder repair","volume":"5","author":"Qin","year":"2014","journal-title":"Stem Cell Res Ther."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/nau.23522","article-title":"Limited accuracy of transurethral and periurethral intrasphincteric injections of cellular suspension","volume":"37","author":"Burdzinska","year":"2018","journal-title":"Neurourol. Urodyn"},{"key":"B58","first-page":"124","article-title":"Comparison of transurethral versus periurethral collagen injection in women with intrinsic sphincter deficiency","volume":"4","author":"Faerber","year":"1998","journal-title":"Tech. Urol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00192-004-1148-6","article-title":"Bulking agents for stress urinary incontinence: short-term results and complications in a randomized comparison of periurethral and transurethral injections","volume":"15","author":"Schulz","year":"2004","journal-title":"Int. Urogynecol. J"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003881.pub4","article-title":"Urethral injection therapy for urinary incontinence in women","author":"Kirchin","year":"2017","journal-title":"Cochr Database Syst Rev."},{"key":"B61","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/nau.24261","article-title":"A novel waterjet technology for transurethral cystoscopic injection of viable cells in the urethral sphincter complex","volume":"39","author":"Jager","year":"2020","journal-title":"Neurourol Urodyn"},{"key":"B62","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/j.1464-410X.2008.07750.x","article-title":"Angiogenic gene modification of skeletal muscle cells to compensate for ageing-induced decline in bioengineered functional muscle tissue","volume":"102","author":"Delo","year":"2008","journal-title":"BJU Int."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1073758\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T08:49:53Z","timestamp":1669970993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1073758\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"references-count":62,"alternative-id":["10.3389\/fmed.2022.1073758"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1073758","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,2]]},"article-number":"1073758"}}